The pharmaceutical firm Aurobindo Pharma Restricted caught fireplace on April 27, 2025 in Penicillin-G Manufacturing Facility situated in Kakinada SEZ in Andhra Pradesh. The hearth began round 10 o’clock within the night time across the coal crusher space. Some equipment have been broken resulting from this incident, however the core manufacturing infrastructure was not affected. The great factor is that nobody is reported to have been injured. This incident of fireplace occurred resulting from fireplace in coal by itself. The corporate is discovering out its precise causes. The corporate mentioned within the trade submitting that the incident shouldn’t be anticipated to have any main influence on the operation or monetary scenario of the group. The loss is being assessed. Facility absolutely insured information -related information. Pharma has assured all stakeholders that facility is totally insured. As a precautionary measure and for substitute of crucial gear, operations in facility are being briefly prevented for an estimated 20 to 25 days interval. This facility is from Aurobindo Pharma’s full-owned step-down subsidiary Lyfius Pharma PRIVATE Restricted. Decrease circuit on the thirteenth consecutive day in Gensol Engineering shares, 92% of 52 weeks of high-to-92% Tutsheer is 2 % and climbing 2 % to Rs 72400 million. The promoters had 51.82 % stake until the tip of March 2025. The inventory closed at Rs 1246.75 with a 2 % acquire on BSE on 28 April. The share value has doubled within the final 2 years. On the similar time, it has climbed 15 % in solely 2 weeks. The corporate was Rs 2,916.63 crore on the standalone foundation within the October-December 2024 quarter. Pure income had been Rs 472 crore and earnings was Rs 8.13 crore per share. Within the monetary yr 2024, the corporate’s income was recorded at Rs 10,645.64 crore, internet revenue of Rs 1,954.14 crore and earnings per share was Rs 32.43 crore.
